Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation.
Limited quarterly history available
Profit Margin needs at least three reported quarters before a meaningful chart is shown.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
N/A
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Hemab Therapeutics Holdings, Inc. Common Stock
Market Cap
$1.33B
Net Profit Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.34B
Net Profit Margin
324.88%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.31B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.37B
Net Profit Margin
-10773.46%
TTM Avg
416506.27%
3Y Avg
203244.58%
5Y Avg
135206.06%
Market Cap
$1.39B
Net Profit Margin
2.93%
TTM Avg
3.18%
3Y Avg
2.55%
5Y Avg
2.48%
Market Cap
$1.40B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.40B
Net Profit Margin
-2728.04%
TTM Avg
-1093.44%
3Y Avg
-2386.05%
5Y Avg
-1590.70%
Market Cap
$1.24B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG) | $1.33B | 0.00% | N/A | N/A | N/A |
| Omeros Corporation (OMER)vs › | $1.34B | 324.88% | 0.00% | 0.00% | 0.00% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | 0.00% | 0.00% | 0.00% | 0.00% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | -10773.46% | 416506.27% | 203244.58% | 135206.06% |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 2.93% | 3.18% | 2.55% | 2.48% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 0.00% | 0.00% | 0.00% | 0.00% |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | -2728.04% | -1093.44% | -2386.05% | -1590.70% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | 0.00% | 0.00% | 0.00% | 0.00% |
| Omada Health (OMDA)vs › | $1.23B | 1.39% | -16.34% | -42.24% | -42.24% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
